Bank of Montreal’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $59K | Sell |
569
-50
| -8% | -$5.28K | ﹤0.01% | 3251 |
|
|
2025
Q4 | $64.7K | Hold |
619
| – | – | ﹤0.01% | 3144 |
|
|
2025
Q3 | $57.3K | Hold |
619
| – | – | ﹤0.01% | 3086 |
|
|
2025
Q2 | $49.4K | Hold |
619
| – | – | ﹤0.01% | 3138 |
|
|
2025
Q1 | $53.6K | Sell |
619
-425
| -41% | -$36.2K | ﹤0.01% | 3054 |
|
|
2024
Q4 | $86.3K | Buy |
1,044
+342
| +49% | +$29.4K | ﹤0.01% | 2987 |
|
|
2024
Q3 | $60.5K | Sell |
702
-1,121
| -61% | -$95.9K | ﹤0.01% | 3374 |
|
|
2024
Q2 | $151K | Sell |
1,823
-1,465
| -45% | -$116K | ﹤0.01% | 3114 |
|
|
2024
Q1 | $265K | Buy |
3,288
+2,097
| +176% | +$162K | ﹤0.01% | 2863 |
|
|
2023
Q4 | $90.9K | Hold |
1,191
| – | – | ﹤0.01% | 3407 |
|
|
2023
Q3 | $94.1K | Sell |
1,191
-187
| -14% | -$14.3K | ﹤0.01% | 3295 |
|
|
2023
Q2 | $106K | Sell |
1,378
-311
| -18% | -$23.7K | ﹤0.01% | 3433 |
|
|
2023
Q1 | $128K | Sell |
1,689
-120
| -7% | -$9.25K | ﹤0.01% | 3176 |
|
|
2022
Q4 | $146K | Sell |
1,809
-295
| -14% | -$22.7K | ﹤0.01% | 3263 |
|
|
2022
Q3 | $156 | Hold |
2,104
| – | – | ﹤0.01% | 3303 |
|
|
2022
Q2 | $160 | Sell |
2,104
-255
| -11% | -$19.3K | ﹤0.01% | 3346 |
|
|
2022
Q1 | $191K | Buy |
2,359
+187
| +9% | +$14.5K | ﹤0.01% | 3475 |
|
|
2021
Q4 | $178K | Hold |
2,172
| – | – | ﹤0.01% | 2987 |
|
|
2021
Q3 | $180K | Sell |
2,172
-159
| -7% | -$12.8K | ﹤0.01% | 3348 |
|
|
2021
Q2 | $191K | Buy |
2,331
+855
| +58% | +$67.9K | ﹤0.01% | 3223 |
|
|
2021
Q1 | $115K | Sell |
1,476
-1,905
| -56% | -$149K | ﹤0.01% | 3334 |
|
|
2020
Q4 | $254K | Sell |
3,381
-436
| -11% | -$29.2K | ﹤0.01% | 3088 |
|
|
2020
Q3 | $246K | Sell |
3,817
-493
| -11% | -$32.2K | ﹤0.01% | 2648 |
|
|
2020
Q2 | $281K | Buy |
4,310
+3,925
| +1,019% | +$244K | ﹤0.01% | 2562 |
|
|
2020
Q1 | $21K | Buy |
385
+25
| +7% | +$1.52K | ﹤0.01% | 3231 |
|
|
2019
Q4 | $23K | Hold |
360
| – | – | ﹤0.01% | 4245 |
|
|
2019
Q3 | $20K | Hold |
360
| – | – | ﹤0.01% | 4092 |
|
|
2019
Q2 | $22K | Hold |
360
| – | – | ﹤0.01% | 4126 |
|
|
2019
Q1 | $23K | Hold |
360
| – | – | ﹤0.01% | 3631 |
|
|
2018
Q4 | $22K | Hold |
360
| – | – | ﹤0.01% | 3610 |
|
|
2018
Q3 | $26K | Hold |
360
| – | – | ﹤0.01% | 3618 |
|
|
2018
Q2 | $24K | Hold |
360
| – | – | ﹤0.01% | 3679 |
|
|
2018
Q1 | $22K | Sell |
360
-190
| -35% | -$12.5K | ﹤0.01% | 3530 |
|
|
2017
Q4 | $35K | Hold |
550
| – | – | ﹤0.01% | 3400 |
|
|
2017
Q3 | $36K | Sell |
550
-200
| -27% | -$12.6K | ﹤0.01% | 3350 |
|
|
2017
Q2 | $47K | Hold |
750
| – | – | ﹤0.01% | 3242 |
|
|
2017
Q1 | $44K | Sell |
750
-1,060
| -59% | -$62K | ﹤0.01% | 3131 |
|
|
2016
Q4 | $102K | Sell |
1,810
-75
| -4% | -$4.32K | ﹤0.01% | 2831 |
|
|
2016
Q3 | $116K | Buy |
1,885
+1,760
| +1,408% | +$115K | ﹤0.01% | 2701 |
|
|
2016
Q2 | $8K | Sell |
125
-1,275
| -91% | -$80.2K | ﹤0.01% | 3632 |
|
|
2016
Q1 | $84K | Buy |
1,400
+1,275
| +1,020% | +$78K | ﹤0.01% | 2866 |
|
|
2015
Q4 | $9K | Sell |
125
-44,132
| -100% | -$3.13M | ﹤0.01% | 3643 |
|
|
2015
Q3 | $2.94M | Buy |
44,257
+384
| +0.9% | +$29.9K | ﹤0.01% | 1145 |
|
|
2015
Q2 | $3.44M | Sell |
43,873
-1,582
| -3% | -$123K | ﹤0.01% | 1185 |
|
|
2015
Q1 | $3.47M | Sell |
45,455
-2,650
| -6% | -$195K | ﹤0.01% | 1159 |
|
|
2014
Q4 | $3.2M | Sell |
48,105
-1,276
| -3% | -$85K | ﹤0.01% | 1210 |
|
|
2014
Q3 | $3.14M | Buy |
49,381
+47,856
| +3,138% | +$2.96M | ﹤0.01% | 1273 |
|
|
2014
Q2 | $93K | Sell |
1,525
-68,480
| -98% | -$3.97M | ﹤0.01% | 2886 |
|
|
2014
Q1 | $3.97M | Sell |
70,005
-16,667
| -19% | -$946K | 0.01% | 1024 |
|
|
2013
Q4 | $4.63M | Sell |
86,672
-8,427
| -9% | -$422K | 0.01% | 860 |
|
|
2013
Q3 | $4.38M | Buy |
95,099
+3,823
| +4% | +$174K | 0.01% | 825 |
|
|
2013
Q2 | $3.86M | Buy |
+91,276
| New | +$3.8M | 0.01% | 829 |
|
Other funds holding PJP
PAM
CI
Bank of Montreal's PJP Position: Q1 2026 in Review
Bank of Montreal reduced its Invesco Pharmaceuticals ETF (PJP) stake by 8.1% in Q1 2026, selling an estimated $5.28K and leaving 569 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #3251.
Bank of Montreal first reported a position in PJP in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.63M in Q4 2013. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.
- Bank of Montreal held 569 shares of Invesco Pharmaceuticals ETF worth $59K as of Q1 2026.
- Bank of Montreal sold 50 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $5.28K.
- Invesco Pharmaceuticals ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #3251 holding.
- Bank of Montreal first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 52 quarters since.
- Bank of Montreal's Invesco Pharmaceuticals ETF position peaked at $4.63M in Q4 2013.
- 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.